Petroleo Brasileiro SA Petrobras
PBR
Strategy
MSTR
NVIDIA
NVDA
Vale SA
VALE
KB Home
KBH
US Stock MarketDetailed Quotes
RNAC Cartesian Therapeutics
- 19.670
- +0.640+3.36%
Close Feb 14 16:00 ET
- 19.670
- 0.0000.00%
Post 16:01 ET
506.02MMarket Cap-0.43P/E (TTM)
19.890High18.930Low51.56KVolume19.200Open19.030Pre Close1.01MTurnover0.55%Turnover RatioLossP/E (Static)25.73MShares41.87052wk High678.28P/B184.26MFloat Cap11.66552wk Low--Dividend TTM9.37MShs Float728.003Historical High--Div YieldTTM5.05%Amplitude11.665Historical Low19.522Avg Price1Lot Size
Cartesian Therapeutics News
Cartesian Therapeutics | 10-Q: Q3 2024 Earnings Report
Cartesian Therapeutics | 8-K: Cartesian Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
Cartesian Therapeutics | 10-Q: Q2 2024 Earnings Report
Cartesian Therapeutics | 8-K: Cartesian Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
Cartesian Therapeutics | 10-Q: Q1 2024 Earnings Report
Cartesian Therapeutics | 8-K: Cartesian Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
Cartesian Therapeutics | 10-K: FY2023 Annual Report
Cartesian Therapeutics | 10-Q: Q3 2023 Earnings Report
SELECTA BIOSCIENCES | 10-Q: Q2 2023 Earnings Report
SELECTA BIOSCIENCES | 8-K: Selecta Biosciences Reports Second Quarter 2023 Financial Results and Updates on Strategic Initiative Designed to Maximize Stockholder Value Associated with SEL-212 Economics
SELECTA BIOSCIENCES | 10-Q: Q1 2023 Earnings Report
SELECTA BIOSCIENCES | 10-K: FY2022 Annual Report
SELECTA BIOSCIENCES | 10-Q: Q3 2022 Earnings Report
SELECTA BIOSCIENCES | 8-K: Selecta Biosciences Reports Third Quarter 2022 Financial Results and Provides Business Update
SELECTA BIOSCIENCES | 10-Q: Q2 2022 Earnings Report
SELECTA BIOSCIENCES | 8-K: Selecta Biosciences Reports Second Quarter 2022 Financial Results and Provides Business Update
SELECTA BIOSCIENCES | 10-Q: Q1 2022 Earnings Report
SELECTA BIOSCIENCES | 8-K: Selecta Biosciences Reports First Quarter 2022 Financial Results and Provides Business Update
SELECTA BIOSCIENCES | 10-K/A: Annual report (Amendment)
SELECTA BIOSCIENCES | 10-K: FY2021 Annual Report
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.